Hepatitis B: a new weapon against an old enemy
- PMID: 34642493
- PMCID: PMC11492204
- DOI: 10.1038/s41591-021-01512-5
Hepatitis B: a new weapon against an old enemy
Conflict of interest statement
Competing interests
The author declares no competing interests.
Figures

Comment on
-
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial.Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4. Epub 2021 Oct 12. Nat Med. 2021. PMID: 34642494 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical